Original document(10 pages)  中文版
    The present invention discloses one kind of quickly releasing orally disintegrated galantamine hydrobromide tablet and one kind of slowly releasing orally disintegrated galantamine hydrobromide tablet and their preparation process. The quickly releasing orally disintegrated galantamine hydrobromide tablet is prepared with galantamine hydrobromide, filler, disintegrant, lubricant, etc and through mixing and direct tabletting. The slowly releasing orally disintegrated galantamine hydrobromide tablet is prepared through adsorbing galantamine hydrobromide with powdered sulfonic acid type ion resin via ion exchange, coating with coating agent, mixing with filler, disintegrant, lubricant, etc and final direct tabletting. The orally disintegrated galantamine hydrobromide tablets of the present invention have fast disintegration, good taste and raised patient's compliance.
Application Number
申请号		 200610096693 Application Date
申请日		 2006.10.18
Title 名称 Orally disintegrated galantamine hydrobromide tablet and its prepn process
Publication Number
公开号		 1931140 Publication Date
公开日		 2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/20;A61K31/55;A61P25/28
Applicant(s) Name
申请人		 Geng Yan
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 wuqi yun
More information 更  多  信  息


 Related patents information
Daidzein drip pill and its preparation method
Ambroxol hydrochloride drop pills and its preparation method
Camptothecine derivative and its preparation
Camptothecine derivatives and their use
Fluorescent quantitative RT-PCR detecting kit of 2-f(o)etoprotein (AFP)mRNA
Camptothecin derivative used as anti-tumor agent and preparation method thereof
Carvedilol dripping pill and its prepn process
Carvedilo oral disintegrating tablet
Novel anti-tumor compound and its preparing method
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.